Cow’s milk, boiled
Summary
Cow's milk (CM) is a major food source, highly valued for its nutritional content and high digestibility. Caseins, e.g. Bos d 8, are the main thermostable CM proteins. Caseins exhibit significant cross-reactivity with homologues from other species, such as goats and sheep. Cow's milk allergy (CMA), including boiled milk allergy, affects about 3% of children in their first three years but is less common in adults. The global prevalence of CMA varies, with environmental and genetic factors playing significant roles in its development. Immediate, delayed and mixed type allergic reactions can occur, which manifest skin, respiratory, gastrointestinal, and severe systemic responses like anaphylaxis. The management of CMA includes avoiding CM and its products, substituting with low allergenic and nutritionally adequate milk alternatives, and oral immunotherapy in selected cases. The diagnosis of IgE-mediated CMA relies on clinical history supported by specific IgE testing, skin prick tests, avoidance regimens, and in some cases oral food challenges.
Epidemiology
Worldwide distribution
CM allergy (CMA) is prevalent among infants and young children during the first year of life, affecting 0.5-3% at the age of 1 year. However, the estimated prevalence of CMA may differ based on variations in study populations, geographical location, clinical history of the patient, IgE testing, oral food challenge (OFC), or self-reporting of allergy.
A systematic review involving 42 studies on CMA in Europe reported the prevalence of CMA to be 1.6% across all age groups (based on OFC or history of CMA). Another review study reported the overall prevalence of CMA to be 0.9% and a country-wise prevalence of 1.8% in the United States (US) (1-5 years), 2.9% (3 years) in the United Kingdom, and 0.5% (3-5 years) in Israel. The average prevalence of confirmed CMA among children (during the first two years) in Europe was found to be 0.54% in a Europe-based multicenter study conducted on 12,049 children (≤ 2 years). Furthermore, the self-reported prevalence of milk allergy in food-allergic children (of all ages) was found to be 21.1% (702/3339) in a US-based cross-sectional survey. A Korean study involving 1353 children and adolescents (0-18 years) reported CM to be one of the most frequent (28.1%) causes of immediate food-allergic reactions.
Risk factors
According to a review study, high-risk populations such as individuals with atopic diseases and multiple food allergies might be prone to CMA. Other CMA-associated risk factors are family history and ethnicity/race. CMA has also been observed to be more prevalent among male children compared to females, whereas this situation reverses during adulthood.
Boiling and processing of milk can destroy bioactive components and beneficial microbes that may play a role in protecting against allergic diseases as suggested in and reviewed in.
Route Of Exposure
Main
IgE-dependent CMA is categorized as a class 1 food allergy, due to sensitization to an ingested allergen.
Secondary
Research has shown that in some children with severe CMA, contact and inhalation might also trigger some allergic reactions.
Clinical Relevance
CMA is regarded as one of the most frequent food allergies among children. CMA presents a spectrum of clinical symptoms of varying severity. Clinical features can manifest as either "immediate" or "delayed" reactions. Approximately 60% of CMA cases are IgE-mediated, though this proportion may vary based on the study population and age. These allergies result in the onset of symptoms within minutes to an hour after allergen exposure. They can affect multiple organs, including the skin (manifesting as urticaria and angioedema), the respiratory system (leading to rhinitis, rhinorrhea, asthma, wheezing, and laryngeal edema/stridor), the gastrointestinal tract (oral allergy syndrome, pain, nausea, flatulence, vomiting, and diarrhea), and the cardiovascular system (resulting in anaphylaxis).
The other 40% of cases are divided between non-IgE-mediated and mixed types. Typical non-IgE-mediated forms of CMA include enteropathy, Heiner syndrome, food protein-induced proctitis, and food protein-induced enterocolitis syndrome.
Non-IgE-mediated reactions typically exhibit a delayed onset, with symptoms appearing within one hour to several days after CM ingestion. Similar to IgE-mediated reactions, these can manifest as various symptoms, most commonly affecting the gastrointestinal system or skin. Gastrointestinal symptoms, such as nausea, bloating, intestinal discomfort, and diarrhea, resemble those of lactose intolerance and may result in misdiagnosis. On the other hand, anaphylaxis is not associated with non-IgE-mediated mechanisms. Additionally, mixed forms of CMA, involving both IgE- and non-IgE-mediated pathways, can exhibit cell-mediated or humoral mechanisms, presenting with both acute and chronic symptoms
Diagnostics
Boiled milk or casein IgE testing can be used to indicate whether a patient with CM sensitization is likely to tolerate cooked or baked milk products.
A correlation exists between allergen-specific IgE levels for milk and the outcomes of OFCs, which are affected by age. Younger children tend to react to lower concentrations of specific IgE antibodies in milk compared to older children.
Prevention And Therapy
Prevention strategies
Allergen Immunotherapy
Cow's milk oral immunotherapy (OIT) can enhance milk tolerance, but its benefits should be weighed against the risk of adverse effects. In a retrospective study of 64 children with cow's milk allergy and high specific IgE levels to casein, 27 children (42.2%) achieved desensitization to fresh milk through an oral food challenge after receiving OIT with heated cow’s milk.
Avoidance
The management of CMA involves avoiding CM and its products and substituting them with an allergenically and nutritionally appropriate milk alternative. The selection of a CM substitute should be based on the age of a child, allergy severity, and the nutritional profile of the substitute.
Cross-Reactivity
IgE-mediated cross-reactivity between caseins from cow and related species can be expected due to casein conserved structural homology. Milk caseins from cow exhibit high amino acid sequence homologies, averaging 96% with buffalo, 91% with sheep, and 88% with goat milk.
Explained Results
Allergen Information
The primary allergens in boiled CM are caseins that retain their allergenicity after heat treatment.
Clinical information
Sensitization to CM heat-stable casein allergens is associated with more severe CMA. Boiled milk or casein IgE testing can be used to indicate whether a patient with CM sensitization is likely to tolerate cooked or baked milk products.
Cross-reactivity
IgE-mediated cross-reactivity between caseins from cow and related species can be expected due to casein conserved structural homology.
References
- Agyemang A, Saf S, Sifers T, Mishoe M, Borres MP, Sampson HA, Nowak-Wegrzyn A. (2019). Utilizing boiled milk sIgE as a predictor of baked milk tolerance in cow's milk allergic children. J Allergy Clin Immunol Pract. 7(6): 2049-2051.
- Antunes IC, Bexiga R, Pinto C, Roseiro LC, Quaresma MAG. (2023). Cow's Milk in Human Nutrition and the Emergence of Plant-Based Milk Alternatives. Foods 12(1).
- Arasi S, Cafarotti A, Fiocchi A. Cow's milk allergy. (2022) Curr Opin Allergy Clin Immunol.1;22(3):181-187.
- Brozek JL, Firmino RT, Bognanni A, Arasi S, Ansotegui I, Assa'ad AH, Bahna SL, Canani RB, Bozzola M, Chu DK, Dahdah L, Dupont C, Dziechciarz P, Ebisawa M, Galli E, Horvath A, Kamenwa R, Lack G, Li H, Martelli A, Nowak-Węgrzyn A, Papadopoulos NG, Pawankar R, Roldan Y, Said M, Sánchez-Borges M, Shamir R, Spergel JM, Szajewska H, Terracciano L, Vandenplas Y, Venter C, Waffenschmidt S, Waserman S, Warner A, Wong GWK, Fiocchi A, Schünemann HJ. (2022). World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) Guideline update - XIV - Recommendations on CMA immunotherapy. World Allergy Organ J. 15(4):100646.
- Cogurlu MT, Uluc NN, Ozanli I, Ozkan YE, Iskender N, Balci S, Simsek IE, Aydogan M. The utility of casein skin prick test and IgE values in predicting anaphylaxis and reactivity to baked milk. Ann Allergy Asthma Immunol. 2025 Mar 31: S1081-1206 (25) 00156-5.
- Deckers J, Marsland BJ, von Mutius E. (2021). Protection against allergies: Microbes, immunity, and the farming effect. Eur J Immunol. 51(10):2387-2398.
- Fiocchi A, Bognanni A, Brożek J, Ebisawa M, Schünemann H. (2022). WAO DRACMA guideline group World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) Guidelines update - I - Plan and definitions. World Allergy Organ J. 15(1):100609.
- Flom JD, Sicherer SH. (2019). Epidemiology of Cow's Milk Allergy. Nutrients 10;11(5):1051.
- Giannetti A, Cipriani F, Indio V, Gallucci M, Caffarelli C, Ricci G. (2019). Influence of Atopic Dermatitis on Cow's Milk Allergy in Children. Medicina (Kaunas) 55(8):460-471.
- Giannetti A, Toschi Vespasiani G, Ricci G, Miniaci A, di Palmo E, Pession A. (2021) Cow's Milk Protein Allergy as a Model of Food Allergies. Nutrients 13(5); 1525-1542.
- Gruzelle V, Juchet A, Martin-Blondel A, Michelet M, Chabbert-Broue A, Didier A. (2020). Benefits of baked milk oral immunotherapy in French children with cow's milk allergy. Pediatr Allergy Immunol. 31(4):364-370.
- Gupta, R. S., E. E. Springston, M. R. Warrier, B. Smith, R. Kumar, J. Pongracic and J. L. Holl (2011). The Prevalence, Severity, and Distribution of Childhood Food Allergy in the United States. Pediatrics 128(1):9-17.
- Haddad C, Banerjee A, Eubanks J, Rana R, Rider NL, Pompeii L, Anvari S (2024) A Second Slice of FPIES: A Single-Center Reappraisal of Pediatric FPIES. J Allergy Clin Immunol Pract 12(8):2118-2126.
- Ito, K., M. Futamura, R. Moverare, A. Tanaka, T. Kawabe, T. Sakamoto and M. P. Borres (2012). The usefulness of casein-specific IgE and IgG4 antibodies in cow's milk allergic children. Clin Mol Allergy 10(1): 1.
- IUIS/WHO Bos taurus. Retrieved May 22, 2025 from: https://allergen.org/search.php?allergensource=Bos+domesticus+%28Bos+taurus%29
- Jensen SA, Fiocchi A, Baars T, Jordakieva G, Nowak-Wegrzyn A, Pali-Schöll I, Passanisi S, Pranger CL, Roth-Walter F, Takkinen K, Assa'ad AH, Venter C, Jensen-Jarolim E; WAO DRACMA guideline group (2022). World Allergy Organ J 15(9):100668.
- Jeong, K., J. Kim, K. Ahn, S. Y. Lee, T. K. Min, B. Y. Pyun, Y. H. Kim, K. W. Kim, M. H. Sohn, K. E. Kim, G. C. Jang, T. W. Song, J. H. Kim, Y. H. Jeon, Y. J. Lee, Y. M. Park, H. Y. Yum, H. H. Kim, W. K. Kim and S. Lee (2017). Age-Based Causes and Clinical Characteristics of Immediate-Type Food Allergy in Korean Children. Allergy Asthma Immunol Res 9(5): 423-430.
- Kaczmarski, M., J. Wasilewska, B. Cudowska, J. Semeniuk, M. Klukowski and E. Matuszewska (2013). The natural history of cow's milk allergy in north-eastern Poland. Adv Med Sci 58(1): 22-30.
- Komata, T., L. Soderstrom, M. P. Borres, H. Tachimoto and M. Ebisawa (2007). The predictive relationship of food-specific serum IgE concentrations to challenge outcomes for egg and milk varies by patient age. J Allergy Clin Immunol 119(5): 1272-1274.
- Linhart B, Freidl R, Elisyutina O, Khaitov M, Karaulov A, Valenta R. (2019). Molecular Approaches for Diagnosis, Therapy and Prevention of Cows Milk Allergy. Nutrients. 29;11(7):1492.
- Luyt, D., H. Ball, N. Makwana, M. R. Green, K. Bravin, S. M. Nasser, A. T. Clark, A. (2014) BSACI guideline for the diagnosis and management of cow's milk allergy. Clin Exp Allergy 44(5): 642-672.
- NCBI. (2020). "Bos taurus." Retrieved 31 May 2024, from https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id=9913.
- Nwaru, B. I., L. Hickstein, S. S. Panesar, G. Roberts, A. Muraro, A. Sheikh, E. F. Allergy and G. Anaphylaxis Guidelines (2014). Prevalence of common food allergies in Europe: a systematic review and meta-analysis. Allergy 69(8): 992-1007.
- Pfefferle PI, Büchele G, Blümer N, Roponen M, Ege MJ, Krauss-Etschmann S, Genuneit J, Hyvärinen A, Hirvonen MR, Lauener R, Pekkanen J, Riedler J, Dalphin JC, Brunekeef B, Braun-Fahrländer C, von Mutius E, Renz H; PASTURE Study Group. (2010) Cord blood cytokines are modulated by maternal farming activities and consumption of farm dairy products during pregnancy: the PASTURE Study. J Allergy Clin Immunol. 125(1):108-115.
- Restani, P., C. Ballabio, C. Di Lorenzo, S. Tripodi and A. Fiocchi (2009). Molecular aspects of milk allergens and their role in clinical events. Anal Bioanal Chem 395(1): 47-56.
- Santoro, A., L. Andreozzi, G. Ricci, C. Mastrorilli and C. Caffarelli (2019). Allergic reactions to cow's milk proteins in medications in childhood. Acta Biomed 90(3-S): 91-93.
- Schocker F, Kull S, Schwager C, Behrends J, Jappe U. (2019). Individual Sensitization Pattern Recognition to Cow's Milk and Human Milk Differs for Various Clinical Manifestations of Milk Allergy. Nutrients.14;11(6):1331.
- Schoemaker, A. A., A. B. Sprikkelman, K. E. Grimshaw, G. Roberts, L. Grabenhenrich, L. Rosenfeld, S. Siegert, R. Dubakiene, O. Rudzeviciene, M. Reche, A. Fiandor, N. G. Papadopoulos, A. Malamitsi-Puchner, A. Fiocchi, L. Dahdah, S. T. Sigurdardottir, M. Clausen, A. Stańczyk-Przyłuska, K. Zeman, E. N. Mills, D. McBride, T. Keil and K. Beyer (2015). Incidence and natural history of challenge-proven cow's milk allergy in European children--EuroPrevall birth cohort. Allergy 70(8): 963-972.
- Sicherer, S. H. (2011). Epidemiology of food allergy. Journal of Allergy and Clinical Immunology 127(3): 594-602.
- Skripak, J. M., E. C. Matsui, K. Mudd and R. A. Wood (2007). The natural history of IgE-mediated cow's milk allergy. J Allergy Clin Immunol 120(5): 1172-1177.
- Verduci, E., S. D'Elios, L. Cerrato, P. Comberiati, M. Calvani, S. Palazzo, A. Martelli, M. Landi, T. Trikamjee and D. G. Peroni (2019). Cow's Milk Substitutes for Children: Nutritional Aspects of Milk from Different Mammalian Species, Special Formula and Plant-Based Beverages. Nutrients 11(8): 1739 - 1755.
- Verhoeckx, K. C. M., Y. M. Vissers, J. L. Baumert, R. Faludi, M. Feys, S. Flanagan, C. Herouet-Guicheney, T. Holzhauser, R. Shimojo, N. van der Bolt, H. Wichers and I. Kimber (2015). Food processing and allergenicity. Food Chem Toxicol 80: 223-240.